Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Barohn

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Muscle & Nerve|September 18, 2009
An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophyBakri Elsheikh, Thomas Prior, Xiaoli Zhang, et al.
Neurology. Clinical Practice|December 20, 2018
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy studyTodd D Levine, Jonathan S Katz, Richard Barohn, et al.
Clinical and Translational Science|August 6, 2015
Frontiers: Integration of a Research Participant Registry with Medical Clinic Registration and Electronic Health RecordsPatricia M Kluding, Jo Denton, T Rene Jamison, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagementZachary Macchi, Yunxia Wang, Dan Moore, et al.
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Behavioural Neurology|December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS PatientsSusan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Behavioural Neurology|December 31, 2019
Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients"Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Neurology|February 12, 2016
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysisValeria A Sansone, James Burge, Michael P McDermott, et al.
Journal of Clinical and Translational Science|October 30, 2019
Enhancing Clinical Research Professionals' Training and Qualifications (ECRPTQ): Recommendations for Good Clinical Practice (GCP) training for investigators and study coordinatorsThomas P Shanley, Nancy A Calvin-Naylor, Ruthvick Divecha, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Muscle & Nerve|September 18, 2009
An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophyBakri Elsheikh, Thomas Prior, Xiaoli Zhang, et al.
Neurology. Clinical Practice|December 20, 2018
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy studyTodd D Levine, Jonathan S Katz, Richard Barohn, et al.
Clinical and Translational Science|August 6, 2015
Frontiers: Integration of a Research Participant Registry with Medical Clinic Registration and Electronic Health RecordsPatricia M Kluding, Jo Denton, T Rene Jamison, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagementZachary Macchi, Yunxia Wang, Dan Moore, et al.
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Behavioural Neurology|December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS PatientsSusan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Behavioural Neurology|December 31, 2019
Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients"Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Neurology|February 12, 2016
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysisValeria A Sansone, James Burge, Michael P McDermott, et al.
Journal of Clinical and Translational Science|October 30, 2019
Enhancing Clinical Research Professionals' Training and Qualifications (ECRPTQ): Recommendations for Good Clinical Practice (GCP) training for investigators and study coordinatorsThomas P Shanley, Nancy A Calvin-Naylor, Ruthvick Divecha, et al.
Pageof 4